Argenx to report first quarter 2021 financial results and business update on may 14, 2021

May 7, 2021 breda, the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that it will host a conference call and audio webcast on friday, may 14, 2021 at 2:30 p.m. cet (8:30 a.m. et) to discuss its first quarter 2021 financial results and provide a business update.
ARGX Ratings Summary
ARGX Quant Ranking